Tamoxifen for hepatocellular carcinoma: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tamoxifen for Hepatocellular Carcinoma: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435942/0/. Accessed 28 April 2024.
Tamoxifen for hepatocellular carcinoma: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435942/0/. Accessed April 28, 2024.
Tamoxifen for hepatocellular carcinoma: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435942/0/
Tamoxifen for Hepatocellular Carcinoma: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435942/0/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tamoxifen for hepatocellular carcinoma: Cochrane systematic review
ID - 435942
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435942/0/
DB - Evidence Central
DP - Unbound Medicine
ER -